| Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune Thrombocytopenia (NCT05459649) | Peking University People's Hospital | 2022-07-20 |
| Baricitinib for Steroid-resistant/Relapse Immune Thrombocytopenia (NCT05446831) | Peking University People's Hospital | 2022-07-13 |
| Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP (NCT05369208) | Sobi, Inc. | 2022-06-15 |
| Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune Thrombocytopenia (NCT05369377) | Peking University People's Hospital | 2022-06-01 |
| The Combination of Zanubrutinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia (NCT05369364) | Peking University People's Hospital | 2022-06-01 |
| The Combination of Tacrolimus and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia (NCT05471050) | Peking University People's Hospital | 2022-03-02 |
| An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP (NCT04943042) | Swedish Orphan Biovitrum | 2022-02-22 |
| A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia (NCT05214391) | Institute of Hematology & Blood Diseases Hospital, China | 2022-02-15 |
| A Study of Zanubrutinib in Patients With ITP (NCT05279872) | Peking University People's Hospital | 2022-01-01 |
| Herombopag + rhTPO in Severe Immune Thrombocytopenia (NCT05328804) | Yin Jie | 2022-01-01 |
| A Study of Orelabrutinib in Patients With ITP (NCT05124028) | Peking University People's Hospital | 2021-12-01 |
| ITP Registry and Accompanying Biospecimen Collection (NCT05152238) | Jena University Hospital | 2021-11-29 |
| SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations (NCT05393999) | Imperial College Healthcare NHS Trust | 2021-11-29 |
| Machine-learning Based Prediction Model in Primary Immune Thrombocytopenia (NCT05116423) | Peking University People's Hospital | 2021-11-10 |
| Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of ≤6 Months (NCT05046327) | Sobi, Inc. | 2021-10-14 |
| Post IVIG Medication in Children With Immune Thrombocytopenia (NCT04741139) | Baylor College of Medicine | 2021-09-02 |
| Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies (NCT04993885) | Institute of Hematology & Blood Diseases Hospital, China | 2021-09-01 |
| A Clinical Trial of the Orelabrutinib in the Management of Refractory ITP (NCT05020288) | Shandong University | 2021-09-01 |
| A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP (NCT05023915) | Shandong University | 2021-08-21 |
| The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia (NCT05353673) | Peking University People's Hospital | 2021-06-01 |
| The Combination of Prednisone and Recombinant Human Thrombopoietin for Treatment of Immune Thrombocytopenia in Pregnancy (NCT05333744) | Peking University People's Hospital | 2021-06-01 |
| Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis (NCT04800458) | University Hospital, Bordeaux | 2021-05-19 |
| Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior Therapy (NCT04904276) | Rigel Pharmaceuticals | 2021-05-18 |
| Hetrombopag for Pediatric Patients With Chronic Immune Thrombocytopenia (NCT04737850) | Jiangsu HengRui Medicine Co., Ltd. | 2021-03-29 |
| Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim (NCT04638829) | Sobi, Inc. | 2021-03-15 |
| Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months (NCT04516967) | Sobi, Inc. | 2021-03-05 |
| The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia (NCT04747080) | Peking University People's Hospital | 2021-03-01 |
| Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP) (NCT04562766) | Principia Biopharma, a Sanofi Company | 2020-12-14 |
| A Study of ATRA in the Treatment of ITP (NCT04618328) | Peking University People's Hospital | 2020-11-01 |
| Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia (NCT04588194) | David Gomez Almaguer | 2020-11-01 |
| A Multicenter Randomized Study of Vitamin D Combined With HD-DXM Versus HD-DXM for the Treatment of ITP (NCT04094805) | Shandong University | 2020-10-01 |
| Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19) (NCT04516837) | Peking University People's Hospital | 2020-08-31 |
| Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER) (NCT04518878) | Peking University People's Hospital | 2020-08-31 |
| A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP (NCT04039477) | Kezar Life Sciences, Inc. | 2020-07-01 |
| Prognostic Value of CD Markers in Immune Thrombocytopenic Purpura (NCT04311593) | Assiut University | 2020-05-01 |
| Phase II Trial of Romiplostim With Danazol in Patients With Eltrombopag-resistant Immune Thrombocytopenia (NCT04289207) | Seoul National University Hospital | 2020-03-01 |
| Effects of Helicobacter Pylori Eradication in Children With Chronic Immune Thrombocytopenic Purpura (NCT03172676) | Assiut University | 2020-01-01 |
| The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia (NCT04217148) | Peking University People's Hospital | 2020-01-01 |
| Eltrombopag in Chronic ITP (NCT04102033) | Assiut University | 2019-11-01 |
| Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP) (NCT04056195) | Oscotec Inc. | 2019-10-11 |
| Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune Cytopenia (NCT03965624) | Assistance Publique - Hôpitaux de Paris | 2019-09-01 |
| A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP) (NCT05566990) | SK Plasma Co., Ltd. | 2019-07-19 |
| Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP (NCT03998982) | Shandong University | 2019-06-25 |
| Observatory of Immunological Thrombopenic Purpura in the Brest Region (NCT06556888) | University Hospital, Brest | 2019-06-20 |
| Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia (NCT05931718) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2019-06-01 |
| Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children (NCT03939637) | Baylor College of Medicine | 2019-05-02 |
| The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP (NCT04368598) | Peking University People's Hospital | 2019-04-01 |
| Association of Platelet Parameters With Bleeding Severity in Children With ITP (NCT03810352) | Boston Children's Hospital | 2019-03-15 |
| Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia (NCT04005638) | University Hospital, Bordeaux | 2019-02-02 |
| Risk Factors for Thrombosis in Immune Thrombocytopenia (NCT03820960) | University Hospital, Toulouse | 2019-02-01 |
| Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITP (NCT03252457) | Shandong University | 2018-09-01 |
| A Study to Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics (NCT03603132) | Jiangsu HengRui Medicine Co., Ltd. | 2018-07-14 |
| Safety and Efficacy of Eltrombopag Plus Pulsed Dexamethasone for Subjects With Idiopathic Thrombocytopenic Purpura (NCT03830749) | Humanity & Health Medical Group Limited | 2018-07-01 |
| Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune Thrombocytopenia (NCT03492515) | Shandong University | 2018-05-01 |
| Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS) (NCT03469661) | Fundacion CRIS de Investigación para Vencer el Cáncer | 2018-04-25 |
| A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP) (NCT03395210) | Principia Biopharma, a Sanofi Company | 2018-03-22 |
| The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia (NCT03460808) | Peking University People's Hospital | 2018-03-10 |
| Severe Immune Cytopenia Registry Www.Sic-reg.Org (NCT03576742) | Medical University of Graz | 2018-03-09 |
| Rituximab Combining Bortezomib Versus Rituximab in Management of ITP (NCT03443570) | Shandong University | 2018-03-01 |
| The Serum Lipid Profiles in ITP: a Retrospective Study (NCT05095896) | Ming Hou | 2018-01-01 |
| The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP (NCT03377439) | Shandong University | 2017-12-01 |
| The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia (NCT03201848) | Qidong Gaitianli Medicines Co., Ltd | 2017-11-16 |
| Newly Diagnosed Immune Thrombocytopenia Testing the Standard Steroid Treatment Against Combined Steroid & Mycophenolate (NCT03156452) | University Hospitals Bristol and Weston NHS Foundation Trust | 2017-10-25 |
| The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia (NCT03304288) | Peking University People's Hospital | 2017-10-11 |
| Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia (NCT03229746) | Assiut University | 2017-08-01 |
| Comparison Between Methyl Prednisolone and Intravenous Dexamethazone in Severe Immune Thrombocytopenic Purpra (NCT03183284) | Assiut University | 2017-06-30 |
| H. Pylori Eradication for Moderate ITP (NCT03177629) | Seoul National University Hospital | 2017-05-23 |
| Evaluation of HRQoL in Adult With Immune Thrombocytopenia in China (NCT03324087) | Shandong University | 2017-05-01 |
| Efficacy and Safety Assessment of a Treatment Combining Rituximab and Belimumab in Adults With Persistent Immune Thrombocytopenia (NCT03154385) | Assistance Publique - Hôpitaux de Paris | 2017-03-13 |
| A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP) (NCT03013114) | Shandong University | 2017-01-01 |
| Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia (NCT03033199) | Shandong University | 2017-01-01 |
| Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia (NCT02649504) | Weill Medical College of Cornell University | 2016-12-01 |
| Proof-of-Concept: A Pilot, Randomized, Double-Blind Study of Oseltamivir Versus Placebo for Immune Thrombocytopenia (NCT03520049) | Unity Health Toronto | 2016-11-01 |
| RP% Measurement by FCM as a Diagnostic Test for ITP (NCT02967328) | Shandong University | 2016-11-01 |
| This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP) (NCT02859909) | Biotest | 2016-11-01 |
| DEX Combined With RTX, CSA and IVIG in the Management of Newly Diagnosed ITP Patients (NCT02834468) | Shandong University | 2016-06-01 |
| Treatment of ITP With Rituximab and / or Accutane (NCT02757196) | Peking University People's Hospital | 2016-05-01 |
| Immunomodulation With Romiplostim in Young Adults With ITP (NCT02760251) | University Hospital, Basel, Switzerland | 2016-04-01 |
| Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia (NCT02298075) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2016-04-01 |
| Thrombocytopenia in Gestational Period (NCT02751593) | Peking University People's Hospital | 2016-01-01 |
| PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP (NCT02566603) | Protalex, Inc. | 2015-11-01 |
| Different Cycles of High-dose Dexamethasone for Initial Management of Primary Immune Thrombocytopenia (ITP) (NCT02642380) | Shandong University | 2015-11-01 |
| Caffeic Acid Combining High-dose Dexamethasone in Management of ITP (NCT02556814) | Shandong University | 2015-09-01 |
| PRTX-100-202 Open-Label, Dose Escalation Study in Adult Patients With ITP (NCT02401061) | Protalex, Inc. | 2015-09-01 |
| Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP) (NCT02868099) | Kyowa Kirin China Pharmaceutical Co., Ltd. | 2015-09-01 |
| A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia (NCT01568333) | Shandong University | 2015-08-01 |
| A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy (NCT02391272) | Shandong University | 2015-03-01 |
| Rituximab, Eltrombopag and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia (NCT02834286) | Hospital Universitario Dr. Jose E. Gonzalez | 2015-03-01 |
| Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP) (NCT02279173) | Amgen | 2014-12-10 |
| Role of Fcgamma Receptors in Immune Thrombocytopenia (ITP) (NCT02821572) | Centre Hospitalier Universitaire Dijon | 2014-10-02 |
| Recombinant Human Thrombopoietin (rhTPO) in Management of Immune Thrombocytopenia (ITP) in Pregnancy (NCT02270801) | Shandong University | 2014-10-01 |
| An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia (NCT02063789) | Green Cross Corporation | 2014-06-01 |
| An Investigation of rhTPO With Different Frequencies in the Management of ITP (NCT02139501) | Shandong University | 2014-05-01 |
| A Multicentre Investigation of 2 Cycles Rituximab Compared With Standard Regimen in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP） (NCT02137681) | Shandong University | 2014-05-01 |
| An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP) (NCT02153060) | Shandong University | 2014-05-01 |
| Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias. (NCT01933035) | Beth Israel Medical Center | 2013-10-01 |
| High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITP (NCT01976195) | Shandong University | 2013-10-01 |
| ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP (NCT01971684) | Boston Children's Hospital | 2013-08-01 |
| French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia (NCT02877706) | University Hospital, Toulouse | 2013-06-01 |
| Alteration of Different Immune Parameters in Immune Thrombocytopenia （ITP） Patients Receiving Eltrombopag Treatment (NCT01864512) | Shandong University | 2013-03-01 |